Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a retrospective clinical study aimed at observing and evaluating the effectiveness and safety of checkpoint inhibitors in the treatment of patients with solid tumors in actual clinical applications. To explore predictors of efficacy patients with unresectable solid tumors receiving checkpoint inhibitors and develop and further validate predictive models.
Epistemonikos ID: 031276ac4b570d36d752f739e563be3078714fe3
First added on: May 14, 2024